Pilot Trial of the First Conversational Agent for Smoking Cessation (QuitBot)
QuitBot
Say "Hello" To Your Digital Coach: Development and Pilot Trial of the First Conversational Agent for Smoking Cessation
3 other identifiers
interventional
404
1 country
1
Brief Summary
Conversational agents (CAs) are computer-powered digital coaches designed to form long-term social-emotional connections with users through conversations. We have developed a CA for cigarette smoking cessation. In a pilot randomized trial (N = 415), we will compare the experimental messaging program (n = 155) with the standard of care national government smoking cessation messaging program (n = 157), and then we will compare immediate (n=51) versus delayed (n=51) access to the the experimental messaging program, to assess 12-week usability, receptivity, and preliminary cessation results in adults in western Washington State and nationally across the US who want to quit smoking.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 29, 2018
CompletedFirst Posted
Study publicly available on registry
July 12, 2018
CompletedStudy Start
First participant enrolled
September 17, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 6, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 2, 2020
CompletedDecember 8, 2020
December 1, 2020
1.2 years
June 29, 2018
December 7, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
30-day point prevalence abstinence
No smoking in the past 30 days, as reported 3 month post treatment.
3 months post randomization
Study Arms (3)
Experimental
EXPERIMENTALThis is the experimental arm of the study. This includes receiving immediate access to the novel/experimental smoking cessation messaging program. Therapy description withheld to protect the integrity of the study.
Control
ACTIVE COMPARATORThis is the control arm of the study. This includes receiving receiving immediate access to the standard of care smoking cessation messaging program. Therapy description withheld to protect the integrity of the study.
Delayed Control
ACTIVE COMPARATORThis is the second control arm of the study. This includes receiving the novel/experimental smoking cessation messaging program after completing the 3-month follow-up survey. Therapy description withheld to protect the integrity of the study.
Interventions
The experimental arm includes an immediate intervention using a novel messaging program for smoking cessation.
The immediate control intervention uses a standard of care messaging program for smoking cessation.
The delayed control intervention uses the novel messaging program for smoking cessation.
Eligibility Criteria
You may qualify if:
- age 18 or older
- smokes at least five cigarettes daily for at least past 12 months
- wants to quit cigarette smoking in the next 14 days
- if concurrently using any other nicotine or tobacco products, wants to quit using them within the next 14days
- resides in western Washington State (in the following counties: Clallam, Grays Harbor, Island, Jefferson, King, Kitsap, Mason, Pierce, San Juan, Skagit, Snohomish, Thurston, and Whatcom)
- interested in learning skills to quit smoking
- willing to be randomly assigned to either condition
- has at least daily access to their own personal smartphone
- has and uses both text messaging and Facebook Messenger on their smartphone
- willing and able to read in English
- not using other smoking cessation interventions (including apps or our other intervention studies).
- willing to complete one 3-month follow-up survey
- willing to provide email, phone, and mailing address.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fred Hutchinson Cancer Research Center
Seattle, Washington, 98109, United States
Related Publications (1)
Bricker JB, Sullivan B, Mull K, Santiago-Torres M, Lavista Ferres JM. Conversational Chatbot for Cigarette Smoking Cessation: Results From the 11-Step User-Centered Design Development Process and Randomized Controlled Trial. JMIR Mhealth Uhealth. 2024 Jul 23;12:e57318. doi: 10.2196/57318.
PMID: 38913882DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jonathan Bricker, PhD
Fred Hutchinson Cancer Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 29, 2018
First Posted
July 12, 2018
Study Start
September 17, 2018
Primary Completion
December 6, 2019
Study Completion
December 2, 2020
Last Updated
December 8, 2020
Record last verified: 2020-12
Data Sharing
- IPD Sharing
- Will not share